HIV-1 Reverse Transcriptase Drug-Resistance Mutations in Chronically Infected Individuals Receiving or Naïve to HAART in Cameroon

The most common first-line, highly active anti-retroviral therapy (HAART) received by individuals infected with HIV-1 in Cameroon is the combination therapy Triomune, comprised of two nucleoside reverse transcriptase inhibitors (NRTI) and one non-NRTI (NNRTI). To examine the efficacy of these drugs...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Burda, Sherri T., Viswanath, Ragupathy, Zhao, Jiangqin, Kinge, Thompson, Anyangwe, Christopher, Tinyami, Erick T., Haldar, Bijayesh, Powell, Rebecca L.R., Jarido, Veronica, Hewlett, Indira K., Nyambi, Phillipe N.
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2958705/
https://ncbi.nlm.nih.gov/pubmed/20029816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.21677
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars